Asiatic Laboratories Limited (DSE:ASIATICLAB)

Market Cap	14.34B +145.7%
Revenue (ttm)	2.90B +125.3%
Net Income	531.35M +158.1%
EPS	4.34 +97.9%
Shares Out	122.39M
PE Ratio	27.00
Forward PE	n/a
Dividend	1.00 (0.85%)
Ex-Dividend Date	Nov 23, 2025

Volume	753,281
Open	117.90
Previous Close	117.30
Day's Range	115.50 - 118.70
52-Week Range	44.20 - 146.90
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Asiatic Laboratories

Asiatic Laboratories Limited manufactures and sells pharmaceutical products in Bangladesh and internationally. The company offers tablets, capsules, oral liquids, powder for suspension, ophthalmic, injectable, and others product. It distributes its products through sales distribution centers and a store. The company also exports its products. Asiatic Laboratories Limited was incorporated in 1970 and is headquartered in Dhaka, Bangladesh.

• Industry: Pharmaceutical Preparations
• Founded: 1970
• Employees: 737
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ASIATICLAB

Financial Performance

In fiscal year 2025, Asiatic Laboratories's revenue was 1.77 billion, an increase of 27.45% compared to the previous year's 1.39 billion. Earnings were 255.36 million, a decrease of -8.30%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 15, 2026

Data Sources Report a data error